Astera Labs, Inc. (ALAB) Income Statement
ALAB 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsALAB revenue and net income
Where ALAB's revenue goes
2025Each bar shows an amount and its share of revenue. ALAB kept 25.7% of revenue as net income.
ALAB profit margins
ALAB growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +115.1% | +120.2% | — | — |
| Gross profit | +113.2% | +122.4% | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | +84.0% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ALAB quarterly EPS vs estimates
Astera Labs beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 3, 2026 (estimate $0.83).
ALAB income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $852.5M | $396.3M | $115.8M | $79.9M |
| Cost of revenue | $207.3M | $93.6M | $36.0M | $21.2M |
| Gross profit | $645.3M | $302.7M | $79.8M | $58.7M |
| Research & development | $304.0M | $200.8M | $73.4M | $73.7M |
| Sales, general & admin | $167.8M | $217.9M | $35.9M | $45.2M |
| Total operating expenses | $471.8M | $418.8M | $109.3M | $118.9M |
| Operating income | $173.4M | −$116.1M | −$29.5M | −$60.2M |
| Interest income | $44.7M | $34.3M | $6.5M | $2.6M |
| Income before taxes | $218.2M | −$81.8M | −$22.9M | −$57.6M |
| Income taxes | −$981,000 | $1.6M | $3.3M | $764,000 |
| Net income | $219.1M | −$83.4M | −$26.3M | −$58.3M |
| EBITDA | $225.0M | −$78.6M | −$21.2M | −$56.8M |
| EPS (diluted) | $1.84 | $1.00 | $0.12 | −$1.71 |
| Gross margin | 75.7% | 76.4% | 68.9% | 73.5% |
| Operating margin | 20.3% | −29.3% | −25.5% | −75.4% |
| Net margin | 25.7% | −21.1% | −22.7% | −73.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $392.4M | $308.4M | $270.6M | $230.6M | $191.9M | $159.4M | $141.1M | $113.1M | $76.8M | $65.3M | $50.5M | $36.9M |
| Cost of revenue | $104.8M | $73.2M | $66.1M | $54.8M | $46.4M | $40.0M | $36.6M | $25.2M | $17.0M | $14.7M | $11.5M | $8.8M |
| Gross profit | $287.6M | $235.1M | $204.5M | $175.8M | $145.6M | $119.4M | $104.4M | $87.9M | $59.9M | $50.5M | $39.0M | $28.1M |
| Research & development | $135.9M | $125.6M | $93.8M | $78.9M | $66.7M | $64.6M | $56.5M | $50.7M | $40.1M | $53.6M | $19.7M | $20.6M |
| Sales, general & admin | $62.4M | $47.7M | $43.7M | $41.5M | $39.1M | $43.6M | $47.8M | $46.1M | $44.1M | $79.9M | $10.4M | $9.5M |
| Total operating expenses | $198.3M | $173.3M | $137.5M | $120.4M | $105.8M | $108.1M | $104.3M | $96.8M | $84.2M | $133.5M | $30.0M | $30.1M |
| Operating income | $89.2M | $61.8M | $67.0M | $55.4M | $39.8M | $11.3M | $144,000 | −$8.9M | −$24.3M | −$83.0M | $9.0M | −$2.0M |
| Interest income | $13.6M | $11.6M | $12.0M | $11.5M | $10.9M | $10.4M | $10.6M | $10.9M | $10.3M | $2.6M | $1.7M | $1.7M |
| Income before taxes | $102.8M | $73.4M | $78.9M | $66.9M | $50.7M | $21.7M | $10.7M | $2.0M | −$14.1M | −$80.4M | $10.7M | −$253,000 |
| Income taxes | −$50.3M | −$6.9M | $33.9M | −$24.3M | −$560,000 | −$10.1M | −$14.0M | $9.6M | −$6.5M | $12.6M | −$3.6M | $2.9M |
| Net income | $153.1M | $80.3M | $45.0M | $91.1M | $51.2M | $31.8M | $24.7M | −$7.6M | −$7.5M | −$93.0M | $14.3M | −$3.1M |
| EBITDA | $106.8M | $77.1M | $81.8M | $68.3M | $52.1M | $22.8M | $11.7M | $2.9M | −$13.4M | −$79.8M | $11.2M | $225,000 |
| EPS (diluted) | $0.49 | $0.61 | $0.58 | $0.49 | $0.44 | $0.33 | $0.37 | $0.23 | $0.13 | $0.27 | $0.12 | — |
| Gross margin | 73.3% | 76.3% | 75.6% | 76.2% | 75.8% | 74.9% | 74.0% | 77.7% | 77.9% | 77.4% | 77.3% | 76.1% |
| Operating margin | 22.7% | 20.1% | 24.7% | 24.0% | 20.7% | 7.1% | 0.1% | −7.9% | −31.7% | −127.1% | 17.9% | −5.4% |
| Net margin | 39.0% | 26.0% | 16.6% | 39.5% | 26.7% | 20.0% | 17.5% | −6.7% | −9.8% | −142.5% | 28.4% | −8.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ALAB's financial statements (latest annual report filed February 20, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ALAB financial results
In fiscal year 2025 (ended December 31, 2025), Astera Labs reported revenue of $852.5 million, up 115.1% from the year before. It had net income of $219.1 million, a net profit margin of 25.7%. Diluted earnings per share came to $1.84.
See the ALAB stock overview for the latest quote and news, or the ALAB chart for price history and technical indicators.
ALAB income statement FAQ
What is Astera Labs's annual revenue?
Astera Labs reported total revenue of $852.5 million for fiscal year 2025, which ended on December 31, 2025. That was up 115.1% from $396.3 million the previous year.
Is Astera Labs profitable?
Yes. Astera Labs reported net income of $219.1 million in fiscal 2025, a net profit margin of 25.7%; its operating margin was 20.3%.
What is Astera Labs's gross margin?
Astera Labs's gross margin was 75.7% in fiscal 2025: for every $100 of revenue, Astera Labs kept $76 after the direct cost of its products and services.
How much does Astera Labs spend on research and development?
Astera Labs spent $304.0 million on research and development in fiscal 2025, 35.7% of revenue.
What are Astera Labs's earnings per share?
Astera Labs earned $1.84 per diluted share in fiscal 2025, compared with $1.00 a year earlier.
When will Astera Labs report its next earnings?
Astera Labs is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes.
When does Astera Labs's fiscal year end?
Astera Labs's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 20, 2026.